PFE vs. VTRS
Compare and contrast key facts about Pfizer Inc. (PFE) and Viatris Inc. (VTRS).
Performance
PFE vs. VTRS - Performance Comparison
Loading graphics...
PFE vs. VTRS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 15.64% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.93% |
VTRS Viatris Inc. | 8.87% | 5.08% | 19.68% | 2.06% | -14.29% | -26.12% | 18.16% |
Fundamentals
PFE:
$161.03B
VTRS:
$15.49B
PFE:
$1.36
VTRS:
-$3.02
PFE:
2.58
VTRS:
1.09
PFE:
1.73
VTRS:
1.05
PFE:
$62.58B
VTRS:
$14.30B
PFE:
$44.01B
VTRS:
$5.01B
PFE:
$15.10B
VTRS:
-$1.13B
Returns By Period
In the year-to-date period, PFE achieves a 15.64% return, which is significantly higher than VTRS's 8.87% return.
PFE
- 1D
- -0.81%
- 1M
- 6.39%
- YTD
- 15.64%
- 6M
- 7.06%
- 1Y
- 25.05%
- 3Y*
- -6.37%
- 5Y*
- 0.03%
- 10Y*
- 4.18%
VTRS
- 1D
- -1.39%
- 1M
- -7.85%
- YTD
- 8.87%
- 6M
- 34.57%
- 1Y
- 72.38%
- 3Y*
- 16.97%
- 5Y*
- 3.59%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PFE vs. VTRS — Risk / Return Rank
PFE
VTRS
PFE vs. VTRS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Viatris Inc. (VTRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PFE | VTRS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.87 | 1.81 | -0.95 |
Sortino ratioReturn per unit of downside risk | 1.38 | 2.48 | -1.10 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.32 | -0.15 |
Calmar ratioReturn relative to maximum drawdown | 1.89 | 3.35 | -1.46 |
Martin ratioReturn relative to average drawdown | 4.26 | 9.96 | -5.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PFE | VTRS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.87 | 1.81 | -0.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | 0.11 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.02 | +0.24 |
Correlation
The correlation between PFE and VTRS is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PFE vs. VTRS - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.07%, more than VTRS's 3.57% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.07% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
VTRS Viatris Inc. | 3.57% | 3.86% | 3.86% | 4.43% | 4.31% | 2.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PFE vs. VTRS - Drawdown Comparison
The maximum PFE drawdown since its inception was -58.96%, which is greater than VTRS's maximum drawdown of -54.33%. Use the drawdown chart below to compare losses from any high point for PFE and VTRS.
Loading graphics...
Drawdown Indicators
| PFE | VTRS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.96% | -54.33% | -4.63% |
Max Drawdown (1Y)Largest decline over 1 year | -11.47% | -18.97% | +7.50% |
Max Drawdown (5Y)Largest decline over 5 years | -58.96% | -47.00% | -11.96% |
Max Drawdown (10Y)Largest decline over 10 years | -58.96% | — | — |
Current DrawdownCurrent decline from peak | -42.26% | -15.96% | -26.30% |
Average DrawdownAverage peak-to-trough decline | -17.34% | -31.61% | +14.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.58% | 6.38% | -0.80% |
Volatility
PFE vs. VTRS - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 6.40%, while Viatris Inc. (VTRS) has a volatility of 7.68%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than VTRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PFE | VTRS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.40% | 7.68% | -1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 16.15% | 23.17% | -7.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.59% | 34.60% | -8.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.46% | 33.14% | -7.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.90% | 33.87% | -9.97% |
Financials
PFE vs. VTRS - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Viatris Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. VTRS - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.
VTRS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Viatris Inc. reported a gross profit of 1.13B and revenue of 3.70B. Therefore, the gross margin over that period was 30.6%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.
VTRS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Viatris Inc. reported an operating income of -265.50M and revenue of 3.70B, resulting in an operating margin of -7.2%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.
VTRS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Viatris Inc. reported a net income of -340.10M and revenue of 3.70B, resulting in a net margin of -9.2%.